¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѵÎÅëÇÐȸ 2023Ãá°èÇмú´ëȸ : 2023-06-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѵÎÅëÇÐȸ 2023Ãá°èÇмú´ëȸ : 2023-06-25
±³À°ÀÏÀÚ : 2023-06-25
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ

±³À°ÁÖÁ¦ : ´ëÇѵÎÅëÇÐȸ 2023Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѵÎÅëÇÐȸ
´ã´çÀÚ : ÀåÁ¤¹®
¿¬¶ôó : 02-6411-7331  

À̸ÞÀÏ : khs.secretariat@innon.co.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, ½Å°æ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, °¡Á¤ÀÇÇаú, ÀÀ±ÞÀÇÇаú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 9 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í <»çÀüµî·Ï>Æò»ýȸ¿ø¹×2022¿¬È¸ºñ³³ºÎÁ¤È¸¿ø40,000¿ø,¹Ì³³Á¤È¸¿ø70,000¿ø,ÁØȸ¿ø(Àü°øÀǹױâŸȸ¿ø,±ºÀÇ°ü,°øº¸ÀÇ)40,000¿ø,ºñȸ¿ø70,000¿ø <ÇöÀåµî·Ï>Æò»ýȸ¿ø¹×2022¿¬È¸ºñ³³ºÎÁ¤È¸¿ø50,000¿ø,¹Ì³³Á¤È¸¿ø80,000¿ø,ÁØȸ¿ø(Àü°øÀǹױâŸȸ¿ø,±ºÀÇ°ü,°øº¸ÀÇ)50,000¿ø,ºñȸ¿ø80,000¿ø <¿öÅ©¼¥-¼±Âø¼ø> 40,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:10~09:30 Reversible cerebral vasoconstriction syndrome ¹ÚÈ«±Õ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:30~09:50 Pediatric migraine ³ªÁöÈÆ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:50~10:10 Other primary headaches ±è¼ö°æ(°æ»óÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:10~10:30 Headache attributed to disorder of homoeostasis Á¶¼öÇö(À»ÁöÀÇ´ë)

Åä·Ð 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:30~10:40 Q & A -(-)

ÈÞ½Ä 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:40~10:50 Coffee Break -(-)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:50~11:06 (±¸¿¬¹ßÇ¥:A ROOM)Treatment outcome of switching between monoclonal antibodies targeting calcitonin gene-related peptide in patients with migraine À±¼ÒÁ¤(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:06~11:22 (±¸¿¬¹ßÇ¥:A ROOM)External validation of the Bern score for diagnosing spontaneous intracranial hypotension ÃÖ¼Ò¿¬(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:22~11:38 (±¸¿¬¹ßÇ¥:A ROOM)A Nationwide Cohort Study on the Association Between Migraine and Parkinson Disease ÇÏ¿ì¼®(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:38~11:54 (±¸¿¬¹ßÇ¥:A ROOM)Changes in frequency and severity of neck pain after the treatment for medication-overuse headache Á¶¼öÁø(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:54~12:10 (±¸¿¬¹ßÇ¥:A ROOM)Effect of body weight on the risk of migraine: a nationwide cohort study ±è³²¿À(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 10:50~11:10 (±¸¿¬¹ßÇ¥:B ROOM)Medication-overuse headache treatment and responsiveness to acute medications °­¹Ì°æ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:10~11:30 (±¸¿¬¹ßÇ¥:B ROOM)Effect of smoking on the development of migraine in women: a nationwide cohort study ±è½Â¾Ö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:30~11:50 (±¸¿¬¹ßÇ¥:B ROOM)Evaluation of Trigger Factors for Pediatric Migraine: A Single-Center Study ¼ÕÇýÁØ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:50~12:10 (±¸¿¬¹ßÇ¥:B ROOM)Disease course and predictors of recurrence in patients with cluster headache: a prospective follow-up study À̹ÌÁö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:10~12:30 Current evidence and practical suggestions for CGRP antagonist ¹®Èñ¼ö(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:30~12:50 How to maintain, stop, and troubleshoot CGRP monoclonal antibodies? ±èº´¼ö(ÀÌÈ­ÀÇ´ë)

Åä·Ð 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:50~13:10 Panel Discussion -(-)

ÈÞ½Ä 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:10~13:30 µÎÅëÇÐȸÁö ÃÖ¿ì¼ö/¿ì¼ö³í¹®»ó ½Ã»ó½Ä -(-)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:30~13:50 Pitfalls of diagnosing pressure-related headaches ±èÁö¿µ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:50~14:10 Management of idiopathic intracranial hypertension ÃÖÀçȯ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:10~14:30 Management of spontaneous intracranial hypotension À̹ÌÁö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:30~14:50 Interventional approach of spontaneous intracranial hypotension ÀÌ¿µÁØ(¼­¿ïÀÇ´ë)

Åä·Ð 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:50~15:00 Q & A -(-)

ÈÞ½Ä 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 15:00~15:10 Coffee Break -(-)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 15:10~15:50 Advances in the genetics of migraine Gisela M. Terwindt(Leiden University Medical Centre (LUMC), Netherlands)

Åä·Ð 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 15:50~16:00 Q & A -(-)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 16:10~16:55 Nerve blocks in headache ¹è´ë¿õ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 25ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 16:55~17:40 Botulinum toxin injection in chronic migraine ¼­Á¾±Ù(°æºÏÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѵÎÅëÇÐȸ 2023Ãá°èÇмú´ëȸ : 2023-06-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¾È¾Ïº´¿ø SCOPE ½ÉÆ÷Áö¾ö 2023 : 2023-06-25
´ÙÀ½±Û 2023³â Á¦13ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2023-06-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 29 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 28 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 33 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 39 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 30 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 22 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 9 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 18 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 12 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 8 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 24 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 13 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 21 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 17 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷